Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1580 of 6351
-
New daily pill could help kids with inherited high cholesterol
Disease control Recruiting nowThis study is designed to learn if enlicitide decanoate is safe and effective to treat children and adolescents with heterozygous familial hypercholesterolemia (HeFH) and high amounts of low-density lipoprotein cholesterol (LDL-C) in the blood. The goals of this study are to lea…
Phase 2/3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New hope for rare blood cancer: platform trial tests multiple drugs at once
Disease control Recruiting nowThis study is a platform trial for the evaluation of new drugs or combination of drugs in relapsed or refractory peripheral T-cell lymphomas. The objective of the study is to generate exploratory data on new drugs or combination of drugs to treat refractory/relapse peripheral T-…
Phase 1/2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Mood-Boosting activities put to the test in schizophrenia
Symptom relief Recruiting nowThis is a study investigating how brief online activities can influence mood and attitudes.
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Personalized radiation aims to outsmart tough pancreatic tumors
Disease control Recruiting nowThe goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer. The main questions the study aims to answer are: * Can ART improve how well radiation therapy targets the most agg…
Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Common drug may keep you out of the catheter club after surgery
Prevention OngoingWhat is this study about? This study is testing whether a common medication called dexamethasone, given through a vein (IV) before surgery, can help prevent a problem called postoperative urinary retention (POUR). POUR means having trouble urinating after surgery, which can cause…
Sponsor: Al-Quds University • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC
-
Exercise and drug combo may fight chemo brain fog
Symptom relief Recruiting nowThis randomized, placebo-controlled trial aims to assess the feasibility, acceptability, and preliminary efficacy of memantine and the University of Carolina (UNC)'s Get Real \& Heel cancer exercise program (MEM+EX) in addressing cancer-related cognitive impairment (CRCI) and und…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Heart lasso: new catheter belt tightens leaky valve without surgery
Disease control PausedBackground: Tricuspid valve regurgitation is a disease where one of the heart valves leaks. The leak affects blood flow. People with this disease may feel breathless and lack energy; they may need to stay in the hospital when fluid builds up in the body. The tricuspid is the mos…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New diabetes pill shows promise in Mid-Stage trial
Disease control OngoingThis multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabete…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Glow-in-the-Dark dye helps surgeons spot hidden cancer
Diagnosis Recruiting nowThe goal of clinical trial is to test an FDA approved drug called Pafolacianine that attaches to cancer cells and lights up when seen through a special camera system in adults with a suspected primary diagnosis, or a high clinical suspicion of gastrointestinal, fore gut, pancreat…
Phase 2 • Sponsor: John Waters • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Could a multiple sclerosis drug help treat a bleeding disorder?
Disease control Recruiting nowA multicenter, open-label, randomized study to report the efficacy and safety of teriflunomide plus high-dose dexamethasone compared to high-dose dexamethasone monotherapy for the first-line treatment of adults with newly diagnosed primary immune thrombocytopenia (ITP).
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:37 UTC
-
New app aims to give teens with suicidal thoughts a lifeline
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate an app to help keep teens and young adults with suicidal thoughts safe. The app includes a safety plan created by adolescents and healthcare providers, and videos to encourage supportive communication and skills for teens and young a…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could a single podcast episode boost body confidence?
Symptom relief CompletedThe goal of this three-arm randomized controlled trial is to evaluate the acceptability and efficacy of two podcast-based interventions -- a podcast with an accompanying journal and the same podcast without a journal -- which aim to improve body confidence among millennial-aged w…
Sponsor: University of the West of England • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Heart age report: a simple tool to spark better blood pressure Self-Care?
Disease control CompletedThis study evaluates the effectiveness of a brief Heart Age-based risk education intervention embedded in routine primary care for older adults with hypertension in China. The intervention uses routine health check data to generate a personalized one-page Heart Age report, delive…
Sponsor: Duke Kunshan University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New Needle-Free blood draw device could slash contamination and pain in ERs
Disease control Recruiting nowBlood cultures (BCs) are a blood test to look for an infection. Two problems with the sample collection are contamination by germs outside of the blood and not collecting enough blood in the tube, resulting in unusable samples. Many patients requiring a BC also have a peripheral …
Sponsor: The University of Queensland • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Teamwork and tech take on type 1 diabetes in new trial
Disease control Recruiting nowThe GLITTER Study 2 is a cluster randomized trial that will evaluate the impact of comprehensive and intensive management, comprising a team, technology, education, and peer resources, on metabolic control and psychological outcomes in patients with type 1 diabetes.
Sponsor: Second Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 26, 2026 12:49 UTC
-
Can a herbal sachet beat chemo fatigue? new trial aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether Nuvastatic can reduce cancer-related fatigue in adult patients with colon cancer undergoing first-line chemotherapy. The main questions it aims to answer are: Does Nuvastatic significantly reduce cancer-related fatigue comp…
Phase 3 • Sponsor: Natureceuticals Sdn Bhd • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Can a phone app help people with HIV kick the smoking habit?
Disease control Recruiting nowThe purpose of this study is to compare the advantages and disadvantages of two approaches for quitting smoking among people living with HIV (PWH). Participants will complete a 24- week (\~6-month) study where the Participants will be assigned to one of two smartphone apps to hel…
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a flickering light headset lift depression?
Symptom relief Recruiting nowThis pilot study evaluates the feasibility, safety, and preliminary efficacy of home-based 60Hz intermittent light therapy in adults with a major depressive episode (MDE). Participants will be randomized in a 2:1 ratio to receive either active or sham 60Hz intermittent light stim…
Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New antibody combo takes on Hard-to-Treat myeloma
Disease control By invitation onlyThe goal of this clinical trial is to learn if the antibody drug HuL001, combined with Lenalidomide/Dexamethasone works to treat Multiple Myeloma patients. It will also learn about the safety and tolerability of the therapeutic combination. The objectives of this study are: 1. …
Phase 1/2 • Sponsor: HuniLife Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Heart drug showdown: which Beta-Blocker best protects ICD patients?
Disease control Recruiting nowThis prospective, multicenter, open-label, randomized comparative effectiveness trial, titled CARVTOP-ICD, evaluates the impact of carvedilol versus metoprolol succinate in patients with heart failure with reduced ejection fraction (HFrEF) and an implantable cardioverter defibril…
Phase 4 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 26, 2026 18:20 UTC